Skip to content
IQity logo

Vision impairment leads to loss of productivity, increased dependence, and greater demand for social support. Yet, ophthalmology is under immense pressure.

Healthcare systems are overloaded and outdated, built on 50-year old models that are now unsustainable. Without innovation, the system is headed toward collapse.

Designed to deliver superior visual outcomes with greater impact and lower cost.

Diagnosis, treatment, and monitoring of the two leading causes of blindness: Cataract & Glaucoma.

Expected launch – Q3 2027

IQ-Scan

Comprehensive eye exams in minutes – anywhere, anytime.


Expected launch – Q3 2026

IQ-Meter

All-in-one diagnostics and laser treatment for lens surgery.


Expected launch – Q3 2026

IQ-SurgiView

Next Gen surgical visualization with AI assistant.


Expected launch – Q2 2028

IQ-Guard

Viscoelastic with enhanced, multifunctional cell protection.


Expected launch – Q3 2029

IQ-Focus

Continious depth of focus IOL.


Expected launch – Q3 2026

IQ-Flow

Triple-action Endoscopic Cyclophotocoagulation device.


Expected launch – Q1 2028

IQ-BioStim

Non-invasive acute and long-term therapy.


Expected launch – Q3 2026

IQ-Universe

Secured data cloud.

IQ-Scan
IQ-Meter
IQ-SurgiView
IQ-Guard
IQ-Focus
IQ-Flow
IQ-BioStim
IQ-Universe
2025
2026
2027
2028
2029

Leadership


Luke Clauson

Luke Clauson

CEO

Board


Farrell (Toby) Tyson

Farrell (Toby) Tyson

Luke Clauson

Luke Clauson

Jim Simms

Jim Simms

Advisory Board


Ike Ahmed, M.D.

Ike Ahmed, M.D.

Barry Seibel, M.D.

Barry Seibel, M.D.

Daniel Chang, M.D.

Daniel Chang, M.D.

Ed Hu, M.D.

Ed Hu, M.D.

Team


Matt Schuster

Matt Schuster

Engineering

Ed Sarver

Ed Sarver

Engineering

Gary Mocnik

Gary Mocnik

Regulatory & Clinical

Neville Bonwit

Neville Bonwit

Operations

Sascha Burger

Sascha Burger

Marketing

Karen Joyce

Karen Joyce

Administration